Pablo Antonio S. S.
- Country
- Spain
- Department
- Respiratory medicine
Research Overview
- Efficacy and Safety Evaluation of Tezepelumab in Adults with Moderate to Very Severe Chronic Obstructive Pulmonary Disease: A Phase III Randomized Controlled Trial
- Efficacy and Safety Evaluation of Verekitug (UPB-101) in Moderate-to-Severe Chronic Obstructive Pulmonary Disease: A Phase 2b Randomized, Double-Blind, Placebo-Controlled Study
- Evaluation of Metformin Hydrochloride on Pulmonary Function in Patients with Chronic Obstructive Pulmonary Disease: A Randomized, Placebo-Controlled Trial
Data & Insights
Has run more than one trial at 17 of 165 partner sites.
Specializations
Respiratory Medicine and Pulmonary Disease
The investigator is involved in clinical research on chronic and acute respiratory disorders, with activity spanning chronic obstructive pulmonary disease, severe asthma, idiopathic pulmonary fibrosis, bronchiectasis, and refractory chronic cough. The portfolio also includes infectious and inflammatory lung conditions such as nontuberculous mycobacterial lung infection, severe community-acquired pneumonia, and severe viral lung infections.
- Chronic obstructive pulmonary disease
- Severe asthma
- Idiopathic pulmonary fibrosis
- Nontuberculous mycobacterial lung infection
- Bronchiectasis
Research activity in this area also extends to allergic rhinitis and chronic rhinosinusitis with nasal polyps, reflecting a broad interest in airway disease and inflammatory respiratory care.
Thoracic Oncology and Solid Tumors
Clinical trial involvement includes a strong focus on lung cancer, especially non-small cell lung cancer, small cell lung cancer, and locally advanced or metastatic thoracic malignancies. The oncology profile also covers head and neck squamous cell carcinoma, esophageal cancer, and gastric cancer, with broader participation in studies of advanced solid tumors.
- Non-small cell lung cancer
- Small cell lung cancer
- Head and neck squamous cell carcinoma
- Esophageal cancer
- Gastric cancer
The investigator is also linked to research on biomarker-defined solid tumors, including cancers with EGFR, HER2, and KRAS alterations.
Hematologic Malignancies and Cell Therapy
Another major area of interest is blood cancers, including acute myeloid leukemia, myelodysplastic syndromes, multiple myeloma, and a wide range of B-cell and T-cell lymphomas. The investigator is also involved in research on relapsed and refractory hematologic malignancies and transplant-associated complications.
- Acute myeloid leukemia
- Myelodysplastic syndromes
- Multiple myeloma
- Diffuse large B-cell lymphoma
- Chronic lymphocytic leukemia
Research activity also includes CAR T-cell therapy, gene-modified T cells, and other immunotherapy-based approaches in hematologic disease.
Autoimmune, Inflammatory, and Allergic Diseases
The investigator’s portfolio includes studies in systemic lupus erythematosus, lupus nephritis, systemic sclerosis, vasculitis, myositis, and immune-mediated kidney disease. Additional interest is seen in atopic dermatitis, urticaria, vitiligo, and food allergy.
- Systemic lupus erythematosus
- Lupus nephritis
- Vasculitis
- Atopic dermatitis
- Urticaria
This clinical area also includes allergic rhinoconjunctivitis, asthma-related allergy, and broader immune system disorders.
Cardiometabolic, Renal, and Neurologic Disorders
Additional trial involvement covers cardiovascular disease, heart failure, atrial fibrillation, atherosclerotic disease, and venous thromboembolism. The investigator is also associated with studies in chronic kidney disease, IgA nephropathy, and amyloidosis, alongside selected neurologic and neurodegenerative disorders such as Alzheimer’s disease, Parkinson’s disease, migraine, and epilepsy.
- Chronic kidney disease
- IgA nephropathy
- Heart failure
- Alzheimer’s disease
- Parkinson’s disease
Research activity in this section also includes obesity, type 2 diabetes, and metabolic dysfunction-associated steatohepatitis.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.
